NCT00379808View on ClinicalTrials.gov

Study of the Arachidonate 5-Lipoxygenase Enzyme in Affecting the Risk for Coronary Heart Disease

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

July 31, 2009

Study Completion Date

August 31, 2009

Conditions
Coronary Heart Disease
Interventions
DRUG

montelukast

10 mg tablet (masked by capsule) daily for 1 month

DRUG

Placebo

1 lactose-containing capsule daily for 1 month

Trial Locations (1)

32601

University of Florida Family Practice Medical Group Clinic, Gainesville

All Listed Sponsors
collaborator

American Heart Association

OTHER

lead

University of Florida

OTHER

NCT00379808 - Study of the Arachidonate 5-Lipoxygenase Enzyme in Affecting the Risk for Coronary Heart Disease | Biotech Hunter | Biotech Hunter